<DOC>
	<DOCNO>NCT02088450</DOCNO>
	<brief_summary>The Syst-Eur Trial concert action European Community 's Medical Health Research Programme . The trial carry consultation World Health Organization , International Society Hypertension , European Society Hypertension World Hypertension League . Syst-Eur multicentre trial design European Working Party High Blood Pressure Elderly ( EWPHE ) , test hypothesis antihypertensive treatment elderly patient isolate systolic hypertension result significant change stroke morbidity mortality . Secondary endpoint include cardiovascular event , myocardial infarction congestive heart failure . To eligible patient must least 60 year old systolic blood pressure average 160-219 mmHg diastolic pressure le 95 mmHg . Patients must give informed consent free major cardiovascular non-cardiovascular disease entry . The patient randomize active treatment placebo . Active treatment consist nitrendipine ( 10-40 mg/day ) , combine enalapril ( 5-20 mg/day ) hydrochlorothiazide ( 12.5-25 mg/day ) , necessary . The patient control group receive match placebo . The drug ( match placebo ) stepwise titrate combined order reduce systolic blood pressure 20 mmHg least level 150 mmHg . Morbidity mortality monitor enable intention-to-treat per-protocol comparison outcome 2 treatment group .</brief_summary>
	<brief_title>Systolic Hypertension Europe</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Nitrendipine</mesh_term>
	<mesh_term>Calcium Channel Blockers</mesh_term>
	<criteria>At least 60 year old . Sitting systolic blood pressure mask placebo , runin phase 160 219 mmHg , sit diastolic blood pressure 95 mmHg stand systolic blood pressure least 140 mmHg Informed consent must obtain Systolic hypertension secondary disorder need specific medical surgical treatment . Retinal haemorrhage papilloedema ; Congestive heart failure Dissecting aortic aneurysm Serum creatinine concentration presentation 180Âµmol/L . History severe nose bleeds . Stroke myocardial infarction year study . Dementia . Substance abuse . Any disorder prohibit sit stand position . Any severe concomitant cardiovascular noncardiovascular disease .</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Cardiovascular complication</keyword>
	<keyword>Clinical trial</keyword>
	<keyword>Elderly</keyword>
	<keyword>Isolated systolic hypertension</keyword>
	<keyword>Stroke</keyword>
</DOC>